CSL Limited, a global biotechnology company based in Australia and Vifor Pharma, a Swiss-based global pharmaceutical company, entered into an agreement for CSL to launch an all-cash public tender offer to acquire all publicly held
Tags :David Waldmeier
Homburger acted as Swiss counsel to ARYZTA in connection with the transaction. The team was led by partner Claude Lambert (Corporate / M&A - pictured) and comprised associates Marc Hanslin (Corporate / M&A) and David
Homburger acted as global transaction counsel to Avaloq and the majority shareholders. The team was led by partner Heinz Schärer (pictured) and included partner David Oser, associates Philippe Baumann and Angela Oppliger and junior
